Browser storage is unavailable. Keep this page open and export your collection before leaving.
Sigma Genetics develops devices that can deliver DNA, RNA, and other charged molecules into cells by using magnetic fields. When compared to conventional electroporation, this technique has several key advantages, which include: the absence of arcing, the ability to scale, and the benefit of being non-invasive for in vivo applications. This platform technology can be applied to a wide range of applications- cell therapies, cancer drug delivery, DNA vaccines, biopharma manufacturing, and cosmetics.
Highly motivated to advance the healthcare field and I aspire to use both my business skills and scientific background to forward the medical industry. Interested in all things bio: cell/gene therapy, computational enzyme design, immunology, diagnostics, health devices, and so much more.
Matthew is a serial entrepreneur with a background in gene therapy and computer security. He has founded or co-founded five biotechnology companies and has played an integral role in the development of several advanced therapeutics, including three first-in-class treatment modalities. He is the author of dozens of patents covering innovations ranging from novel transfection technologies, immune cell programming, in vivo production of therapeutic proteins, senolytics, longevity, and oncology.
Source-based assessment · automated evidence rules
The captured homepage does not clearly identify the listed business.
Maturity is an evidence-based assessment, not a success rating. It may understate the current stage where evidence is limited. Coverage records documented areas, not a complete or independently audited company history.
Our best pricing upfront. Straightforward to compare. Simple to buy. Shop cell culture media and buffers from Bramante Biologics.
Same product type · Hardware device
abinitio bio is the AI-native operating platform for drug development and manufacturing.
Founders · Product · How it works
Same category · Biotech pharma
Our autonomous biodefense capabilities ensure validated point-of-care diagnostics for emerging biological threats are developed in days, not 12+ months.
Founders
Same category · Biotech pharma
Anthrogen is engineering post-modality biology. Today's modalities reflect historical contingencies in biological progress, not fundamental categories. We develop the AI systems that design modular biological machines and the…
Founders · Product
Same category · Biotech pharma
Anto is building a foundation model for microbial communities, making the gut microbiome computable for the first time. We predict drug toxicity and efficacy across diverse populations and fix drugs so they work for everyone — solving…
Founders · Product
Same category · Biotech pharma
Generative AI Medical Writing Solution for Biotech, Life Sciences, Pharma & Medical Devices | Artos AI. Book a demo online.
Customers · Founders · Product
Same category · Biotech pharma
